L. T. Lima

ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib.

M. Hirata, R. Hirata, E. Guerra-Shinohara, 2012, Blood cells, molecules & diseases.

Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia

M. Hirata, R. Hirata, V. Hungria, 2014, Medical Oncology.

CALR mutations screening in wild type JAK2(V617F) and MPL(W515K/L) Brazilian myeloproliferative neoplasm patients.

M. Chauffaille, M. Mitne-Neto, E. Guerra-Shinohara, 2015, Blood cells, molecules & diseases.

ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib

E. Guerra-Shinohara, A. Rodrigues, Greyce Kelly Steinhorst Alcantara, 2014, Oncology letters.